檢索結果 - Luca Valenti

Refine Results
  1. 1
    A randomized trial of iron depletion in patients with nonalcoholic fatty liver disease and hyperferritinemia

    A randomized trial of iron depletion in patients with nonalcoholic fatty liver disease and hyperferritinemia 由 Luca Valenti

    出版 2014
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  2. 2
    The mitochondrial superoxide dismutase A16V polymorphism in the cardiomyopathy associated with hereditary haemochromatosis

    The mitochondrial superoxide dismutase A16V polymorphism in the cardiomyopathy associated with hereditary haemochromatosis 由 Luca Valenti

    出版 2004
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    Diagnostic and therapeutic implications of the association between ferritin level and severity of nonalcoholic fatty liver disease

    Diagnostic and therapeutic implications of the association between ferritin level and severity of nonalcoholic fatty liver disease 由 Luca Valenti

    出版 2012
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  4. 4
    Telomeres, NAFLD and Chronic Liver Disease

    Telomeres, NAFLD and Chronic Liver Disease 由 Benedetta Donati, Luca Valenti

    出版 2016
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  5. 5
    A Nutrigenomic Approach to Non-Alcoholic Fatty Liver Disease

    A Nutrigenomic Approach to Non-Alcoholic Fatty Liver Disease 由 Paola Dongiovanni, Luca Valenti

    出版 2017
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  6. 6
    Hepatic fat as clinical outcome and therapeutic target for nonalcoholic fatty liver disease

    Hepatic fat as clinical outcome and therapeutic target for nonalcoholic fatty liver disease 由 Serena Pelusi, Luca Valenti

    出版 2018
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  7. 7
    Update on NAFLD genetics: From new variants to the clinic

    Update on NAFLD genetics: From new variants to the clinic 由 Eric Trépo, Luca Valenti

    出版 2020
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  8. 8
    Redefining fatty liver disease classification in 2020

    Redefining fatty liver disease classification in 2020 由 Luca Valenti, Serena Pelusi

    出版 2020
    獲取全文
    Carta
    加到收藏夾
    Saved in:
  9. 9
    Genetic Factors in the Pathogenesis of Nonalcoholic Fatty Liver and Steatohepatitis

    Genetic Factors in the Pathogenesis of Nonalcoholic Fatty Liver and Steatohepatitis 由 Paola Dongiovanni, Stefano Romeo, Luca Valenti

    出版 2015
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  10. 10
    Unraveling the genetics of fatty liver in obese children: Additive effect of P446L GCKR and I148M PNPLA3 polymorphisms

    Unraveling the genetics of fatty liver in obese children: Additive effect of P446L GCKR and I148M PNPLA3 polymorphisms 由 Luca Valenti, Anna Alisi, Valério Nobili

    出版 2012
    獲取全文
    Carta
    加到收藏夾
    Saved in:
  11. 11
    Nuclear Trapping of the Forkhead Transcription Factor FoxO1 via Sirt-dependent Deacetylation Promotes Expression of Glucogenetic Genes

    Nuclear Trapping of the Forkhead Transcription Factor FoxO1 via Sirt-dependent Deacetylation Promotes Expression of Glucogenetic Genes 由 David Frescas, Luca Valenti, Domenico Accili

    出版 2005
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  12. 12
    Risk of Serious Bacterial and Non‐Bacterial Infections in People With <scp>MASLD</scp>

    Risk of Serious Bacterial and Non‐Bacterial Infections in People With <scp>MASLD</scp> 由 Giovanni Targher, Herbert Tilg, Luca Valenti

    出版 2025
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  13. 13
    Beyond hereditary hemochromatosis: New insights into the relationship between iron overload and chronic liver diseases

    Beyond hereditary hemochromatosis: New insights into the relationship between iron overload and chronic liver diseases 由 Silvia Fargion, Luca Valenti, Anna Ludovica Fracanzani

    出版 2010
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  14. 14
    Genetic Predisposition in NAFLD and NASH: Impact on Severity of Liver Disease and Response to Treatment

    Genetic Predisposition in NAFLD and NASH: Impact on Severity of Liver Disease and Response to Treatment 由 Paola Dongiovanni, Quentin M. Anstee, Luca Valenti

    出版 2013
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  15. 15
    Leveraging Human Genetics to Identify Potential New Treatments for Fatty Liver Disease

    Leveraging Human Genetics to Identify Potential New Treatments for Fatty Liver Disease 由 Stefano Romeo, Arun J. Sanyal, Luca Valenti

    出版 2020
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  16. 16
    Nutritional therapy for nonalcoholic fatty liver disease

    Nutritional therapy for nonalcoholic fatty liver disease 由 Paola Dongiovanni, Claudia Lanti, Patrizia Riso, Luca Valenti

    出版 2015
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  17. 17
    The role of insulin resistance in nonalcoholic steatohepatitis and liver disease development – a potential therapeutic target?

    The role of insulin resistance in nonalcoholic steatohepatitis and liver disease development – a potential therapeutic target? 由 Paola Dongiovanni, Raffaela Rametta, Marica Meroni, Luca Valenti

    出版 2015
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  18. 18
    COVID‐19 and liver disease

    COVID‐19 and liver disease 由 Jian Sun, Alessio Aghemo, Alejandro Forner, Luca Valenti

    出版 2020
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  19. 19
    Genetic predisposition similarities between NASH and ASH: Identification of new therapeutic targets

    Genetic predisposition similarities between NASH and ASH: Identification of new therapeutic targets 由 Cristiana Bianco, Elia Casirati, Francesco Malvestiti, Luca Valenti

    出版 2021
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  20. 20
    PNPLA3 as a therapeutic target for fatty liver disease: the evidence to date

    PNPLA3 as a therapeutic target for fatty liver disease: the evidence to date 由 Alessandro Cherubini, Elia Casirati, Melissa Tomasi, Luca Valenti

    出版 2021
    獲取全文
    Revisão
    加到收藏夾
    Saved in:

檢索工具: